Clinical Trial

The Born in Guangzhou Cohort Study (BIGCS)

Study acronym: BIGCS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2015-08-16; most recent amendment 2024-02-22.
Trial Details
NCT Number NCT02526901
Lead Sponsor Guangzhou Women and Children's Medical Center
Collaborators: University of Birmingham
Conditions Intrauterine Hyperglycemia, Pregnancy Outcomes, Neurodevelopment, Immune Development, Childhood Obesity, Host and Microbiome
Enrollment 30,000 participants
Start Date 2012-02-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-26